James T. Willerson, MD
President and Medical Director
Texas Heart Institute
Houston, Texas

Acknowledgement of Support
We acknowledge the following for their support of the live event from which this activity was derived: Astrellas Pharma, Inc., AstraZeneca, Medtronic, Inc., Merck & Co., Inc., Pfizer Inc., St. Jude Medical, Inc. and Thoratec Corporation. No grants were received for the production of these online enduring materials.

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Estimated Study Time
The estimated time to complete this activity, including review of the materials and completion of the course assessment is 3.5 hours.

Repurposing Statement
If you previously completed and received credit for the live CME-sponsored symposium entitled, 9th Texas Update in Cardiovascular Advancements on December 4-5, 2009, please note that you will not receive credit for completing this activity. Participants who take part in an identical activity, even in order to validate learning or to clarify specific topics, cannot claim, nor will the Texas Heart Institute award, duplicate credit for the activity.

Term of Approval
January 21, 2010 through January 21, 2013. Continuation of CME credit from January 21, 2013 depends upon a thorough review of the content for currency and accuracy.

Peer Review
In January 2010, this continuing medical education activity was reviewed for currency and accuracy of content by Patrick J. Hogan, MD, FACC, Director Learning Resource Center and Co-Chairman, Medical Education Committee, Texas Heart Institute, Houston, TX.

Disclosure of Relationships
It is the intent of the Texas Heart Institute to ensure that its educational mission and its continuing medical activities in particular, should not be influenced by the special interests of individuals associated with its program.

Faculty Disclosure
In accordance with the guidelines of the Accreditation Council for Continuing Medical Education, faculty members have disclosed their relationships, with either the manufacturers of commercial products discussed, or the corporate organizations offering educational grants for the live continuing medical education activity.

Eric Boerwinkle, PhD does not have any disclosures relevant to this program.  

Benjamin Cheong, MD discloses the following, relevant to this program: Grant/Research Support—St. Jude Medical, Inc. and Bracco.  

R. David Fish, MD does not have any disclosures relevant to this program.  

Peter Jones, MD discloses the following, relevant to this program: Consultant—Abbott Laboratories, Roche, AstraZeneca, and Daiichi Sankyo Co., Ltd.; Speakers' Bureau—Abbott Laboratories, Merck/Schering Plough Pharmaceuticals, and AstraZeneca.  

A. J. Marian, MD does not have any disclosures relevant to this program but will discuss unlabeled or investigational uses of products.  

James T. Willerson, MD (Program Director/Speaker) does not have any disclosures relevant to this program.  

James M. Wilson, MD does not have any disclosures relevant to this program but will discuss unlabeled or investigational uses of products.

In addition, the peer reviewer, Patrick J. Hogan, MD has nothing to disclose relevant to this program.

This enduring material comprises 9 presentations. By clicking on the course materials link below, you acknowledge that you have reviewed the CME information provided above. After viewing all presentations, you must complete an assessment and evaluation to obtain CME credit for this activity.